Disposition of Intravenous Pyrimethamine in Healthy Volunteers
A proportion of patients with AIDS and toxoplasmic encephalitis (TE) sustain low plasma pyrimethamine concentrations during oral treatment, possibly because of incomplete and variable bioavailability. We wanted to develop a safe, practicable intravenous (i.v.) formulation of pyrimethamine and charac...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
2000
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89934/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10817730/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.6.1691-1693.2000 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
